603669 灵康药业
已收盘 08-20 15:00:00
资讯
新帖
简况
灵康药业(603669)披露2026年半年度报告,8月17日股价上涨1.11%
证券之星 · 08-17
灵康药业(603669)披露2026年半年度报告,8月17日股价上涨1.11%
灵康药业(603669)2026年中报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 08-16
灵康药业(603669)2026年中报简析:营收净利润同比双双增长,盈利能力上升
每周股票复盘:灵康药业(603669)Q2净利同比增206.1%
证券之星 · 08-16
每周股票复盘:灵康药业(603669)Q2净利同比增206.1%
灵康药业(603669)6月30日股东户数2.73万户,较上期增加7.31%
证券之星 · 08-15
灵康药业(603669)6月30日股东户数2.73万户,较上期增加7.31%
图解灵康药业中报:第二季度单季净利润同比增长206.10%
证券之星 · 08-15
图解灵康药业中报:第二季度单季净利润同比增长206.10%
股市必读:灵康药业新发布《关于子公司产品注射用石杉碱甲中选省际联盟采购的公告》
证券之星 · 08-14
股市必读:灵康药业新发布《关于子公司产品注射用石杉碱甲中选省际联盟采购的公告》
灵康药业(603669.SH)子公司产品注射用石杉碱甲中选省际联盟采购
智通财经网 · 08-12
灵康药业(603669.SH)子公司产品注射用石杉碱甲中选省际联盟采购
每周股票复盘:灵康药业(603669)灵康转债或触发下修条款
证券之星 · 08-09
每周股票复盘:灵康药业(603669)灵康转债或触发下修条款
股市必读:灵康药业新发布《关于“灵康转债”预计满足转股价格修正条件的提示性公告》
证券之星 · 08-05
股市必读:灵康药业新发布《关于“灵康转债”预计满足转股价格修正条件的提示性公告》
灵康药业(603669)披露关于“灵康转债”预计满足转股价格修正条件的提示性公告,8月3日股价上涨1.3%
证券之星 · 08-03
灵康药业(603669)披露关于“灵康转债”预计满足转股价格修正条件的提示性公告,8月3日股价上涨1.3%
每周股票复盘:灵康药业(603669)周内两次登龙虎榜
证券之星 · 07-26
每周股票复盘:灵康药业(603669)周内两次登龙虎榜
7月22日灵康药业(603669)龙虎榜数据
证券之星 · 07-22
7月22日灵康药业(603669)龙虎榜数据
灵康药业(603669)披露股票交易异常波动公告,7月20日股价下跌10.05%
证券之星 · 07-20
灵康药业(603669)披露股票交易异常波动公告,7月20日股价下跌10.05%
异动快报:灵康药业(603669)7月20日10点5分触及跌停板
证券之星 · 07-20
异动快报:灵康药业(603669)7月20日10点5分触及跌停板
CRO概念板块短线走低,灵康药业、昭衍新药、美诺华跌停
每日经济新闻 · 07-20
CRO概念板块短线走低,灵康药业、昭衍新药、美诺华跌停
每周股票复盘:灵康药业(603669)半年报预盈2300万元
证券之星 · 07-19
每周股票复盘:灵康药业(603669)半年报预盈2300万元
异动快报:灵康药业(603669)7月16日14点55分触及跌停板
证券之星 · 07-16
异动快报:灵康药业(603669)7月16日14点55分触及跌停板
股市必读:灵康药业(603669)预计2026年1-6月扣除后营业收入约:24,200万元
证券之星 · 07-15
股市必读:灵康药业(603669)预计2026年1-6月扣除后营业收入约:24,200万元
灵康药业预计上半年净利约2300万元,同比扭亏
北京商报 · 07-14
灵康药业预计上半年净利约2300万元,同比扭亏
异动快报:灵康药业(603669)7月13日11点16分触及涨停板
证券之星 · 07-13
异动快报:灵康药业(603669)7月13日11点16分触及涨停板
加载更多
公司概况
公司名称:
灵康药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2015-05-28
主营业务:
灵康药业集团股份有限公司的主营业务是化药处方药的研发、生产和销售。公司的主要产品是肠外营养药、抗感染药、消化系统药、心脑血管药。公司先后获得“中国创新力医药企业”、“中国药品研发综合实力百强榜”等荣誉、灵康制药“一种奥美拉唑钠半水合物及其制备方法”专利荣获中国专利优秀奖,继续保持公司在行业内的竞争优势。
发行价格:
11.70
{"stockData":{"symbol":"603669","market":"SH","secType":"STK","nameCN":"灵康药业","latestPrice":6.05,"timestamp":1787209202000,"preClose":5.9,"halted":0,"volume":31580249,"delay":0,"changeRate":0.0254,"floatShares":712000000,"shares":712000000,"eps":-0.1915,"marketStatus":"已收盘","change":0.15,"latestTime":"08-20 15:00:00","open":6,"high":6.45,"low":6,"amount":195000000,"amplitude":0.0763,"askPrice":6.06,"askSize":600,"bidPrice":6.05,"bidSize":1377,"shortable":0,"etf":0,"ttmEps":-0.1915,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787275800000},"marketStatusCode":5,"adr":0,"adjPreClose":5.9,"symbolType":"stock","openAndCloseTimeList":[[1787189400000,1787196600000],[1787202000000,1787209200000]],"highLimit":6.49,"lowLimit":5.31,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":712331165,"isCdr":false,"pbRate":7.42,"roa":"--","roe":"3.35%","epsLYR":-0.27,"committee":0.192135,"marketValue":4310000000,"turnoverRate":0.0443,"status":0,"floatMarketCap":4310000000},"requestUrl":"/m/hq/s/603669/","defaultTab":"news","newsList":[{"id":"2660489923","title":"灵康药业(603669)披露2026年半年度报告,8月17日股价上涨1.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660489923","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660489923?lang=zh_cn&edition=full","pubTime":"2026-08-17 17:54","pubTimestamp":1786960484,"startTime":"0","endTime":"0","summary":"截至2026年8月17日收盘,灵康药业报收于6.36元,较前一交易日上涨1.11%,最新总市值为45.3亿元。该股当日开盘6.3元,最高6.45元,最低6.15元,成交额达1.48亿元,换手率为3.29%。近日,灵康药业披露《2026年半年度报告》。公告显示,公司总资产为1,124,036,756.48元,较上年度末增长1.56%;归属于上市公司股东的净资产为641,401,611.76元,较上年度末增长3.40%。公司半年度不进行利润分配或资本公积转增股本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700024132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","BK0033","603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659179304","title":"灵康药业(603669)2026年中报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2659179304","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659179304?lang=zh_cn&edition=full","pubTime":"2026-08-16 06:02","pubTimestamp":1786831346,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期灵康药业发布2026年中报。截至本报告期末,公司营业总收入2.57亿元,同比上升50.03%,归母净利润2111.27万元,同比上升159.08%。按单季度数据看,第二季度营业总收入1.71亿元,同比上升40.69%,第二季度归母净利润1815.68万元,同比上升206.1%。本报告期灵康药业盈利能力上升,毛利率同比增幅131.06%,净利率同比增幅139.38%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600001252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659965176","title":"每周股票复盘:灵康药业(603669)Q2净利同比增206.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659965176","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659965176?lang=zh_cn&edition=full","pubTime":"2026-08-16 03:11","pubTimestamp":1786821070,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘,灵康药业报收于6.29元,较上周的6.21元上涨1.29%。股本股东变化股东户数变动截至2026年6月30日,灵康药业股东户数为2.73万户,较3月31日增加1857.0户,增幅7.31%。业绩披露要点财务报告2026年上半年,灵康药业主营收入2.57亿元,同比上升50.03%;归母净利润2111.27万元,同比上升159.08%;扣非净利润1842.08万元,同比上升140.45%。第二季度单季度主营收入1.71亿元,同比上升40.69%;单季度归母净利润1815.68万元,同比上升206.1%;单季度扣非净利润1740.71万元,同比上升163.0%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","BK0033","603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659178941","title":"灵康药业(603669)6月30日股东户数2.73万户,较上期增加7.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659178941","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659178941?lang=zh_cn&edition=full","pubTime":"2026-08-15 17:03","pubTimestamp":1786784592,"startTime":"0","endTime":"0","summary":"证券之星消息,近日灵康药业披露,截至2026年6月30日公司股东户数为2.73万户,较3月31日增加1857.0户,增幅为7.31%。在化学制药行业个股中,灵康药业股东户数低于行业平均水平,截至6月30日,化学制药行业平均股东户数为3.62万户。从股价来看,2026年3月31日至2026年6月30日,灵康药业区间涨幅为23.26%,在此期间股东户数增加1857.0户,增幅为7.31%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081500012613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0239","BK0056","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659237991","title":"图解灵康药业中报:第二季度单季净利润同比增长206.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659237991","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659237991?lang=zh_cn&edition=full","pubTime":"2026-08-15 01:21","pubTimestamp":1786728105,"startTime":"0","endTime":"0","summary":"证券之星消息,灵康药业2026年中报显示,上半年度公司主营收入2.57亿元,同比上升50.03%;归母净利润2111.27万元,同比上升159.08%;扣非净利润1842.08万元,同比上升140.45%;其中2026年第二季度,公司单季度主营收入1.71亿元,同比上升40.69%;单季度归母净利润1815.68万元,同比上升206.1%;单季度扣非净利润1740.71万元,同比上升163.0%;负债率42.94%,投资收益-50.58万元,财务费用1092.42万元,毛利率41.31%。财报数据概要请见下图:本文数据来源于灵康药业2026年中报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081500001948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659161996","title":"股市必读:灵康药业新发布《关于子公司产品注射用石杉碱甲中选省际联盟采购的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2659161996","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659161996?lang=zh_cn&edition=full","pubTime":"2026-08-14 02:11","pubTimestamp":1786644671,"startTime":"0","endTime":"0","summary":"截至2026年8月13日收盘,灵康药业报收于6.29元,上涨1.45%,换手率3.3%,成交量23.49万手,成交额1.49亿元。当日关注点交易信息汇总:8月13日主力资金净流入207.66万元,占总成交额1.4%。公司公告汇总:子公司注射用石杉碱甲(瑞立速)中选34种药品省际联盟集中带量采购,采购周期2年,覆盖全国多个省区市。该产品适用于良性记忆障碍、痴呆患者及脑器质性病变引起的记忆障碍,亦用于重症肌无力治疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400001355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","BK0239","603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658922755","title":"灵康药业(603669.SH)子公司产品注射用石杉碱甲中选省际联盟采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2658922755","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658922755?lang=zh_cn&edition=full","pubTime":"2026-08-12 15:44","pubTimestamp":1786520658,"startTime":"0","endTime":"0","summary":"智通财经APP讯,灵康药业 发布公告,公司全资子公司海南灵康制药有限公司参加了由河南省牵头,对34种药品开展省际联盟集中带量采购工作的投标工作,根据“34种药品省际联盟采购办公室”于2026年8月11日在河南省医药集中采购平台发布的《34种药品省际联盟采购公告(八)》,子公司产品注射用石杉碱甲中选此次采购。此次中选有利于提升注射用石杉碱甲在认知障碍、重症肌无力治疗领域的全国市场占有率,提升公司品牌影响力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0033","BK0056","603669","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658673028","title":"每周股票复盘:灵康药业(603669)灵康转债或触发下修条款","url":"https://stock-news.laohu8.com/highlight/detail?id=2658673028","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658673028?lang=zh_cn&edition=full","pubTime":"2026-08-09 02:17","pubTimestamp":1786213030,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,灵康药业报收于6.21元,较上周的5.39元上涨15.21%。本周,灵康药业8月7日盘中最高价报6.27元。本周关注点公司公告汇总:灵康转债已连续10个交易日收盘价低于转股价格85%,或触发下修条款。公司公告汇总关于“灵康转债”预计满足转股价格修正条件的提示性公告灵康药业集团股份有限公司发布关于“灵康转债”预计满足转股价格修正条件的提示性公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603669","BK0056","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657565870","title":"股市必读:灵康药业新发布《关于“灵康转债”预计满足转股价格修正条件的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657565870","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657565870?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:32","pubTimestamp":1785868333,"startTime":"0","endTime":"0","summary":"公司公告汇总:灵康药业提示“灵康转债”预计满足转股价格向下修正条件,若未来20个交易日内再有5个交易日收盘价低于5.53元/股,将触发修正条款。公司公告汇总关于“灵康转债”预计满足转股价格修正条件的提示性公告灵康药业集团股份有限公司发布关于“灵康转债”预计满足转股价格修正条件的提示性公告。公司将在触发条件当日召开董事会审议是否修正转股价格,并及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","BK0033","603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656777633","title":"灵康药业(603669)披露关于“灵康转债”预计满足转股价格修正条件的提示性公告,8月3日股价上涨1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656777633","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656777633?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:40","pubTimestamp":1785768027,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘,灵康药业报收于5.46元,较前一交易日上涨1.3%,最新总市值为38.89亿元。近日,灵康药业集团股份有限公司发布关于“灵康转债”预计满足转股价格修正条件的提示性公告。若未来20个交易日内有5个交易日收盘价继续低于该标准,可能触发转股价格向下修正条款。公司将在触发条件当日召开董事会审议是否修正转股价格,并及时履行信息披露义务。此前公司已于2026年6月16日决定不向下修正转股价格。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","603669","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654052787","title":"每周股票复盘:灵康药业(603669)周内两次登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2654052787","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654052787?lang=zh_cn&edition=full","pubTime":"2026-07-26 01:50","pubTimestamp":1785001824,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,灵康药业报收于4.97元,较上周的6.57元下跌24.35%。本周,灵康药业7月20日盘中最高价报6.08元。本周关注点交易信息汇总:灵康药业因价格振幅达15%及三日累计跌幅偏离值超20%两度登龙虎榜。交易信息汇总龙虎榜上榜沪深交易所2026年7月22日公布信息显示,灵康药业因有价格涨跌幅限制的日价格振幅达到15%的前五只证券登上龙虎榜,为近5个交易日内第2次上榜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","BK0033","603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653975672","title":"7月22日灵康药业(603669)龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2653975672","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653975672?lang=zh_cn&edition=full","pubTime":"2026-07-22 17:53","pubTimestamp":1784713996,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年7月22日公布的交易公开信息显示,灵康药业因有价格涨跌幅限制的日价格振幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年7月22日收盘,灵康药业报收于5.45元,上涨2.44%,换手率11.79%,成交量84.01万手,成交额4.53亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200036964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0239","BK0033","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652114792","title":"灵康药业(603669)披露股票交易异常波动公告,7月20日股价下跌10.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652114792","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652114792?lang=zh_cn&edition=full","pubTime":"2026-07-20 22:30","pubTimestamp":1784557828,"startTime":"0","endTime":"0","summary":"截至2026年7月20日收盘,灵康药业报收于5.91元,较前一交易日下跌10.05%,最新总市值为42.1亿元。该股当日开盘5.91元,最高6.08元,最低5.91元,成交额达1.33亿元,换手率为3.15%。近日,灵康药业集团股份有限公司发布股票交易异常波动公告。公告显示,公司股票于2026年7月16日、7月17日、7月20日连续三个交易日内收盘价格跌幅偏离值累计超过20%,构成股票交易异常波动。公司董事、高管及控股股东在异常波动期间无买卖股票行为。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000039765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0239","BK0033","BK0056"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652266407","title":"异动快报:灵康药业(603669)7月20日10点5分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2652266407","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652266407?lang=zh_cn&edition=full","pubTime":"2026-07-20 10:10","pubTimestamp":1784513429,"startTime":"0","endTime":"0","summary":"证券之星7月20日盘中消息,10点5分灵康药业(603669)触及跌停板。其所属行业化学制药目前上涨。领涨股为益方生物。该股为阿尔茨海默病,幽门螺杆菌概念,医药概念热股,当日阿尔茨海默病概念上涨1.6%,幽门螺杆菌概念概念上涨1.44%,医药概念上涨1.4%。7月17日的资金流向数据方面,主力资金净流入700.94万元,占总成交额3.58%,游资资金净流出148.16万元,占总成交额0.76%,散户资金净流出552.78万元,占总成交额2.83%。近5日资金流向一览见下表:灵康药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000006673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","BK0033","603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652126699","title":"CRO概念板块短线走低,灵康药业、昭衍新药、美诺华跌停","url":"https://stock-news.laohu8.com/highlight/detail?id=2652126699","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652126699?lang=zh_cn&edition=full","pubTime":"2026-07-20 09:39","pubTimestamp":1784511595,"startTime":"0","endTime":"0","summary":"7月20日,CRO概念板块短线走低,灵康药业、昭衍新药、美诺华跌停,万邦医药、百奥赛图、百花医药、峆一药业、双成药业等跟跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607203812244470.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607203812244470.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06127","BK0056","BK1141","BK0216","603669","603538","BK0033","BK0239","BK1576","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652309782","title":"每周股票复盘:灵康药业(603669)半年报预盈2300万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652309782","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652309782?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:45","pubTimestamp":1784400311,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,灵康药业报收于6.57元,较上周的6.18元上涨6.31%。来自业绩披露要点:灵康药业预计2026年上半年归属净利润盈利约2300万元,实现扭亏为盈。业绩披露要点灵康药业发布业绩预告,预计2026年1-6月扣除后营业收入约24,200万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000863.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","BK0033","603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651115294","title":"异动快报:灵康药业(603669)7月16日14点55分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2651115294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651115294?lang=zh_cn&edition=full","pubTime":"2026-07-16 15:01","pubTimestamp":1784185261,"startTime":"0","endTime":"0","summary":"证券之星7月16日盘中消息,14点55分灵康药业(603669)触及跌停板。其所属行业化学制药目前上涨。领涨股为博瑞医药。该股为民营医院,流感,西藏概念概念热股,当日民营医院概念上涨2.56%,流感概念上涨1.12%,西藏概念概念上涨0.97%。7月15日的资金流向数据方面,主力资金净流出1185.11万元,占总成交额1.51%,游资资金净流出2356.02万元,占总成交额3.0%,散户资金净流入3541.13万元,占总成交额4.51%。近5日资金流向一览见下表:灵康药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600018988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0056","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651748350","title":"股市必读:灵康药业(603669)预计2026年1-6月扣除后营业收入约:24,200万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651748350","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651748350?lang=zh_cn&edition=full","pubTime":"2026-07-15 01:45","pubTimestamp":1784051113,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘,灵康药业报收于7.4元,上涨8.82%,换手率14.27%,成交量101.65万手,成交额7.28亿元。当日关注点交易信息汇总:灵康药业因日价格振幅达15%登上龙虎榜,为近5个交易日内首次上榜。业绩披露要点业绩预告预计2026年1-6月归属净利润盈利约2300万元;扣非后净利润盈利约2000万元;营业收入约2.5亿元;扣除后营业收入约24,200万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500002163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651297109","title":"灵康药业预计上半年净利约2300万元,同比扭亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2651297109","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651297109?lang=zh_cn&edition=full","pubTime":"2026-07-14 21:08","pubTimestamp":1784034480,"startTime":"0","endTime":"0","summary":"7月14日晚间,灵康药业(维权)(603669)发布2026年半年度业绩预告显示,公司预计2026年上半年实现归属净利润2300万元左右,上年同期为亏损3573.37万元,同比扭亏为盈。灵康药业表示,本期公司实现扭亏为盈,主要系报告期内加大集采中标品种推广力度、发挥渠道优势拓展非集采品种市场,同时依托销售体系优势深化医药流通及代理业务,带动经营业绩向好。(文章来源:北京商报)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-14/doc-inihusyc8055763.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-14/doc-inihusyc8055763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0056","BK0033","603669"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651605571","title":"异动快报:灵康药业(603669)7月13日11点16分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2651605571","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651605571?lang=zh_cn&edition=full","pubTime":"2026-07-13 11:25","pubTimestamp":1783913126,"startTime":"0","endTime":"0","summary":"证券之星7月13日盘中消息,11点16分灵康药业(603669)触及涨停板。其所属行业化学制药目前下跌。领涨股为新天地。该股为阿尔茨海默病,医药,流感概念热股,当日阿尔茨海默病概念上涨0.71%,医药概念上涨0.18%,流感概念上涨0.17%。7月10日的资金流向数据方面,主力资金净流出331.73万元,占总成交额1.28%,游资资金净流出53.51万元,占总成交额0.21%,散户资金净流入385.24万元,占总成交额1.49%。近5日资金流向一览见下表:灵康药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300011117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603669","BK0239","BK0033","BK0056"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787259353011,"stockEarnings":[{"period":"1week","weight":-0.0382},{"period":"1month","weight":0.1372},{"period":"3month","weight":0.407},{"period":"6month","weight":0.3124},{"period":"1year","weight":0.0614},{"period":"ytd","weight":0.3268}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0102},{"period":"3month","weight":-0.0509},{"period":"6month","weight":-0.0437},{"period":"1year","weight":0.0365},{"period":"ytd","weight":-0.0164}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"灵康药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"27263人(较上一季度增加7.31%)","perCapita":"26128股","listingDate":"2015-05-28","address":"西藏自治区山南市乃东区国道349号(结巴乡段)20号","registeredCapital":"71233万元","survey":" 灵康药业集团股份有限公司的主营业务是化药处方药的研发、生产和销售。公司的主要产品是肠外营养药、抗感染药、消化系统药、心脑血管药。公司先后获得“中国创新力医药企业”、“中国药品研发综合实力百强榜”等荣誉、灵康制药“一种奥美拉唑钠半水合物及其制备方法”专利荣获中国专利优秀奖,继续保持公司在行业内的竞争优势。","listedPrice":11.7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"灵康药业(603669)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供灵康药业(603669)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"灵康药业,603669,灵康药业股票,灵康药业股票老虎,灵康药业股票老虎国际,灵康药业行情,灵康药业股票行情,灵康药业股价,灵康药业股市,灵康药业股票价格,灵康药业股票交易,灵康药业股票购买,灵康药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"灵康药业(603669)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供灵康药业(603669)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}